Z-1320-2015 Class III Terminated

Recalled by Roche Molecular Systems, Inc. — Branchburg, NJ

FDA device recall Z-1320-2015 was initiated by Roche Molecular Systems, Inc. on Jan 13, 2015 and is designated Class III. Reason for recall: False positive results for Exon 20 insertion mutations are being detected with the cobas¿ EGFR Mutation Test, kit batch T08661. The recall status is terminated (terminated Dec 11, 2017). Affected quantity: 190 kits.

Recall details

Product Type
Devices
Report Date
Apr 1, 2015
Initiation Date
Jan 13, 2015
Termination Date
Dec 11, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
190 kits

Product description

cobas¿ EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay

Reason for recall

False positive results for Exon 20 insertion mutations are being detected with the cobas¿ EGFR Mutation Test, kit batch T08661.

Distribution pattern

Foreign

Code information

T08661

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1320-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1320-2015. Report a data issue: hello@regdatalab.com.